Business Activities
Global Sales

Orient Pharma actively penetrates overseas markets to look for global partners (Licensing out), and provides high-quality products to patients, to create a win-win partnership.

Partners

We build strong partnerships in Asia, Europe, and America. With more than 400 representatives focusing on Taiwan, China, Philippines, Singapore, Malaysia, Hong Kong, and Vietnam, sales force of Orient Europharma group provides the most professional services to satisfy customer needs.

Marketing Strategies

Short-term
Offers domestic and overseas OEM and contract development services.
Actively looks for overseas partners after early clinical studies for products under development are completed.
Promotes generic products through collaboration with US large wholesalers .
Provides domestic and overseas services for clinical studies and product registration.
Long-term
Penetrates US generic market.
Focuses on products with high entry barrier and patent protective products to earn higher profits.
Develops new products, focuses on China and ASEAN generic markets to maximize the economies of scale.

Product List

RLD Generic name Indication Formulation Strength Package
Glucovance® Glyburide + Metformin Type II diabetes Tablet 5mg/500mg 14 x 4, Box
Livalo® in US Pitavastatin Hyperlipidemia FC Tablet 1, 2, 4mg 90, Bot
Livalo® in Japan Pitavastatin Hyperlipidemia FC Tablet 2, 4mg 14 x 2, Box
Mykrox® Metolazone Hypertension Tablet 0.5mg 14 x 6, Box
Soma® Carisoprodol Muscle pain relief Tablet 350mg 100, 500, 1000, Bot
Glyset® Miglitol Type II diabetes FC Tablet 25, 50, 100mg 100, Bot
Ectrin® Erdosteine Mucolytic agent (COPD, bronnchitis) Capsule 300mg 10 x 2, 10 x 10, Box
Cellcept® Mycophenolate mofetil Prophylaxis of organ rejection in pts receiving transplants Capsule 250mg 10 x 2, Box
Diabeta® Glyburide Type II diabetes Tablet 1.5, 2.5, 5mg 100, 500, 1000, Bot
Vancocin® Vancomycin Infection Capsule 125, 250mg 10 x 2, Box
Exelon® Rivastigmine Alzheimer's disease Patch 4.6mg/24hrs,
9mg loading
Box

回上方